vs
NEOGEN CORP（NEOG）与ROYAL GOLD INC（RGLD）财务数据对比。点击上方公司名可切换其他公司
ROYAL GOLD INC的季度营收约是NEOGEN CORP的1.7倍（$375.3M vs $224.7M），ROYAL GOLD INC净利率更高（24.9% vs -7.1%，领先32.0%），ROYAL GOLD INC同比增速更快（85.3% vs -2.8%），过去两年ROYAL GOLD INC的营收复合增速更高（58.8% vs -0.9%）
Neogen Corporation是一家1982年成立、总部位于美国密歇根州兰辛的跨国食品安全企业，专注提供各类检测试剂盒及相关产品，用于筛查食品中的有害成分。目前业务覆盖美国、加拿大、英国、欧洲部分地区、墨西哥、巴西、印度、中国等多个国家，旗下拥有超100款药物检测试剂盒产品，可检测约300种相关违禁物质。
Royal Gold Inc.是全球领先的贵金属流权与特许权经营企业，收购并管理多元化的矿业项目流权、净熔炼收益特许权及相关权益，资产覆盖黄金、白银、铜等品类，业务遍及多地区，无需直接承担采矿运营风险。
NEOG vs RGLD — 直观对比
营收规模更大
RGLD
是对方的1.7倍
$224.7M
营收增速更快
RGLD
高出88.1%
-2.8%
净利率更高
RGLD
高出32.0%
-7.1%
两年增速更快
RGLD
近两年复合增速
-0.9%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $224.7M | $375.3M |
| 净利润 | $-15.9M | $93.6M |
| 毛利率 | 47.5% | 64.6% |
| 营业利润率 | -2.4% | 56.2% |
| 净利率 | -7.1% | 24.9% |
| 营收同比 | -2.8% | 85.3% |
| 净利润同比 | 96.5% | -12.8% |
| 每股收益（稀释后） | $-0.07 | $1.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NEOGRGLD
| Q4 25 | $224.7M | $375.3M | ||
| Q3 25 | $209.2M | $252.1M | ||
| Q2 25 | $225.4M | $209.6M | ||
| Q1 25 | $221.0M | $193.4M | ||
| Q4 24 | $231.3M | $202.6M | ||
| Q3 24 | $217.0M | $193.8M | ||
| Q2 24 | $236.8M | $174.1M | ||
| Q1 24 | $228.8M | $148.9M |
净利润NEOGRGLD
| Q4 25 | $-15.9M | $93.6M | ||
| Q3 25 | $36.3M | $126.8M | ||
| Q2 25 | $-612.3M | $132.3M | ||
| Q1 25 | $-10.9M | $113.5M | ||
| Q4 24 | $-456.3M | $107.4M | ||
| Q3 24 | $-12.6M | $96.2M | ||
| Q2 24 | $-5.4M | $81.2M | ||
| Q1 24 | $-2.0M | $47.2M |
毛利率NEOGRGLD
| Q4 25 | 47.5% | 64.6% | ||
| Q3 25 | 45.4% | 73.6% | ||
| Q2 25 | 41.2% | 72.6% | ||
| Q1 25 | 49.9% | 69.4% | ||
| Q4 24 | 49.0% | 70.3% | ||
| Q3 24 | 48.4% | 66.6% | ||
| Q2 24 | 47.9% | 64.7% | ||
| Q1 24 | 51.1% | 58.4% |
营业利润率NEOGRGLD
| Q4 25 | -2.4% | 56.2% | ||
| Q3 25 | -7.7% | 64.4% | ||
| Q2 25 | -271.1% | 67.7% | ||
| Q1 25 | 2.4% | 63.6% | ||
| Q4 24 | -197.8% | 65.9% | ||
| Q3 24 | 1.0% | 61.3% | ||
| Q2 24 | 5.5% | 58.6% | ||
| Q1 24 | 5.3% | 50.7% |
净利率NEOGRGLD
| Q4 25 | -7.1% | 24.9% | ||
| Q3 25 | 17.4% | 50.3% | ||
| Q2 25 | -271.6% | 63.1% | ||
| Q1 25 | -4.9% | 58.7% | ||
| Q4 24 | -197.3% | 53.0% | ||
| Q3 24 | -5.8% | 49.7% | ||
| Q2 24 | -2.3% | 46.6% | ||
| Q1 24 | -0.9% | 31.7% |
每股收益（稀释后）NEOGRGLD
| Q4 25 | $-0.07 | $1.04 | ||
| Q3 25 | $0.17 | $1.92 | ||
| Q2 25 | $-2.82 | $2.01 | ||
| Q1 25 | $-0.05 | $1.72 | ||
| Q4 24 | $-2.10 | $1.63 | ||
| Q3 24 | $-0.06 | $1.46 | ||
| Q2 24 | $-0.02 | $1.23 | ||
| Q1 24 | $-0.01 | $0.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $145.3M | $233.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.1B | $7.2B |
| 总资产 | $3.4B | $9.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NEOGRGLD
| Q4 25 | $145.3M | $233.7M | ||
| Q3 25 | $138.9M | $172.8M | ||
| Q2 25 | $129.0M | $248.2M | ||
| Q1 25 | $127.7M | $240.8M | ||
| Q4 24 | $140.2M | $195.5M | ||
| Q3 24 | $120.5M | $127.9M | ||
| Q2 24 | $170.9M | $74.2M | ||
| Q1 24 | $168.4M | $137.9M |
总债务NEOGRGLD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $50.0M | ||
| Q1 24 | — | — |
股东权益NEOGRGLD
| Q4 25 | $2.1B | $7.2B | ||
| Q3 25 | $2.1B | $3.4B | ||
| Q2 25 | $2.1B | $3.3B | ||
| Q1 25 | $2.7B | $3.2B | ||
| Q4 24 | $2.7B | $3.1B | ||
| Q3 24 | $3.1B | $3.0B | ||
| Q2 24 | $3.1B | $3.0B | ||
| Q1 24 | $3.1B | $2.9B |
总资产NEOGRGLD
| Q4 25 | $3.4B | $9.5B | ||
| Q3 25 | $3.4B | $4.5B | ||
| Q2 25 | $3.4B | $3.6B | ||
| Q1 25 | $4.0B | $3.5B | ||
| Q4 24 | $4.1B | $3.4B | ||
| Q3 24 | $4.5B | $3.3B | ||
| Q2 24 | $4.5B | $3.3B | ||
| Q1 24 | $4.6B | $3.3B |
负债/权益比NEOGRGLD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.02× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.4M | $241.7M |
| 自由现金流经营现金流 - 资本支出 | $7.8M | — |
| 自由现金流率自由现金流/营收 | 3.5% | — |
| 资本支出强度资本支出/营收 | 5.2% | — |
| 现金转化率经营现金流/净利润 | — | 2.58× |
| 过去12个月自由现金流最近4个季度 | $-18.5M | — |
8季度趋势，按日历期对齐
经营现金流NEOGRGLD
| Q4 25 | $19.4M | $241.7M | ||
| Q3 25 | $10.9M | $174.0M | ||
| Q2 25 | $16.4M | $152.8M | ||
| Q1 25 | $19.5M | $136.4M | ||
| Q4 24 | $40.3M | $141.1M | ||
| Q3 24 | $-17.9M | $136.7M | ||
| Q2 24 | $26.7M | $113.5M | ||
| Q1 24 | $-30.2M | $138.3M |
自由现金流NEOGRGLD
| Q4 25 | $7.8M | — | ||
| Q3 25 | $-13.1M | — | ||
| Q2 25 | $349.0K | — | ||
| Q1 25 | $-13.4M | — | ||
| Q4 24 | $23.1M | — | ||
| Q3 24 | $-56.3M | — | ||
| Q2 24 | $2.5M | — | ||
| Q1 24 | $-62.3M | — |
自由现金流率NEOGRGLD
| Q4 25 | 3.5% | — | ||
| Q3 25 | -6.3% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | -6.1% | — | ||
| Q4 24 | 10.0% | — | ||
| Q3 24 | -26.0% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | -27.2% | — |
资本支出强度NEOGRGLD
| Q4 25 | 5.2% | — | ||
| Q3 25 | 11.5% | — | ||
| Q2 25 | 7.1% | — | ||
| Q1 25 | 14.9% | — | ||
| Q4 24 | 7.4% | — | ||
| Q3 24 | 17.7% | — | ||
| Q2 24 | 10.2% | — | ||
| Q1 24 | 14.0% | — |
现金转化率NEOGRGLD
| Q4 25 | — | 2.58× | ||
| Q3 25 | 0.30× | 1.37× | ||
| Q2 25 | — | 1.15× | ||
| Q1 25 | — | 1.20× | ||
| Q4 24 | — | 1.31× | ||
| Q3 24 | — | 1.42× | ||
| Q2 24 | — | 1.40× | ||
| Q1 24 | — | 2.93× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NEOG
| Other | $109.2M | 49% |
| Bacterial And General Sanitation | $44.9M | 20% |
| Services | $25.7M | 11% |
| Natural Toxins And Allergens | $20.4M | 9% |
| Animal Care | $8.9M | 4% |
| Genomics Services | $6.3M | 3% |
| Biosecurity Products | $4.6M | 2% |
| Life Sciences | $1.4M | 1% |
RGLD
| Gold | $216.9M | 58% |
| Pueblo Viejo | $47.3M | 13% |
| Andacollo | $32.6M | 9% |
| Silver | $32.1M | 9% |
| Other | $27.2M | 7% |
| Copper | $13.7M | 4% |
| Cortez Legacy Zone | $5.4M | 1% |
